| Literature DB >> 31544020 |
Deeksha Pandey1, Chaitanya Maturi1, Bhanu Pratap Singh Dhakar1, Gazal Jain1, Keerti Kyalakond1.
Abstract
INTRODUCTION: Stress urinary incontinence (SUI), though is more prevalent than many chronic diseases, has remained largely underreported and underdiagnosed condition. We aimed to find the improvement in the quality of life (QoL) of women with SUI after individual interventions, namely mid-urethral sling (MUS), pelvic floor muscle training (PFMT), and no treatment/control group, as primary treatment modalities.Entities:
Keywords: King's Health Questionnaire; pelvic floor muscle training; quality of life; stress urinary incontinence; tension-free vaginal tape
Year: 2019 PMID: 31544020 PMCID: PMC6743231 DOI: 10.4103/GMIT.GMIT_72_18
Source DB: PubMed Journal: Gynecol Minim Invasive Ther ISSN: 2213-3070
Figure 1Distribution of the study population
Figure 2Health-care-seeking rate for urinary incontinence in our cohort
Correlation between the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form scores and choice of intervention
| ICIQ-UI SF scores, mean±SD | |||
|---|---|---|---|
| TVT-O | 20 | 14.3±3.18 | 0.001 |
| PFMT | 50 | 10.46±3.37 | |
| No treatment | 18 | 9.5±3.69 |
Values are given as mean±SD, *P value: One-way ANOVA, <0.05 is significant. ICIQ-UI SF: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form, SD: Standard deviation, TVT-O: Tension-free vaginal tape-obturator, PFMT: Pelvic floor muscle training, ANOVA: Analysis of variance
Baseline scores in the King’s Health Questionnaire before intervention in the three groups (n=77)
| Tool number | Domains | TVT-O group ( | PFMT group ( | Nil intervention group ( | |
|---|---|---|---|---|---|
| KHQ1 | General health perceptions | 67.5±20.03 | 54.48±18.02 | 44.44±16.66 | <0.001 |
| KHQ2 | Incontinence impact | 74.99±23.88 | 51.27±18.48 | 51.84±24.21 | <0.001 |
| KQH3 | Role limitations | 64.99±24.72 | 48.71±23.99 | 35.18±32.74 | 0.001 |
| KHQ4 | Physical limitations | 67.49±29.85 | 49.14±30.09 | 38.88±33.33 | 0.008 |
| KHQ5 | Social limitations | 63.60±29.25 | 36.74±30.06 | 27.77±34.01 | 0.001 |
| KHQ6 | Personal relationships | 34.41±36.43 | 16.92±32.10 | 11.11±19.80 | 0.051 |
| KHQ7 | Emotions | 63.88±24.94 | 39.59±29.81 | 27.15±25.90 | <0.001 |
| KHQ8 | Sleep/energy | 29.16±26.42 | 15.38±16.83 | 13.88±16.41 | 0.024 |
| KHQ9 | Severity measures | 57.49±25.34 | 44.43±22.07 | 28.69±21.62 | 0.001 |
| KHQ10 | Symptom severity score | 7.95±4.37 | 5.38±3.70 | 4.72±4.32 | 0.030 |
Values are given as mean±SD, P value: Multivariate ANOVA, <0.05 is significant. TVT-O: Tension-free vaginal tape-obturator, PFMT: Pelvic floor muscle training, ANOVA: Analysis of variance, KHQ: King’s Health Questionnaire, SD: Standard deviation
Comparison of various domains of King’s Health Questionnaire before and 3 months after tension-free vaginal tape-obturator (n=20)
| Domains | Before TVT-O (t0) | After TVT-O (t3) | Change in points | ||
|---|---|---|---|---|---|
| KHQ1 | General health perception | 67.5±20.03 | 27.5±7.69 | 40 | <0.0001 |
| KHQ2 | Incontinence impact | 74.99±23.88 | 16.66±17.09 | 58.33 | <0.0001 |
| KQH3 | Role limitations | 64.99±24.72 | 11.66±15.38 | 53.33 | <0.0001 |
| KHQ4 | Physical limitations | 67.49±29.85 | 19.16±13.5 | 48.33 | <0.0001 |
| KHQ5 | Social limitations | 63.60±29.25 | 14.44±18.05 | 49.16 | <0.0001 |
| KHQ6 | Personal relationships | 34.41±36.43 | 4.99±7.83 | 29.42 | 0.0019 |
| KHQ7 | Emotions | 63.88±24.94 | 12.22±11.34 | 51.66 | <0.0001 |
| KHQ8 | Sleep/energy | 29.16±26.42 | 7.49±10.07 | 51.67 | 0.004 |
| KHQ9 | Severity measures | 57.49±25.34 | 13.74±14.62 | 43.75 | <0.0001 |
| KHQ10 | Symptom severity scale | 7.95±4.37 | 2.35±1.03 | 5.6 | <0.0003 |
Values are given as mean±SD, P value: Paired t-test/Wilcoxon signed-rank test, <0.05 is significant. TVT-O: Tension-free vaginal tape-obturator, KHQ: King’s Health Questionnaire, SD: Standard deviation
Comparison of various domains of King’s Health Questionnaire before and 3 months after pelvic floor muscle training (n=39)
| Domains | Before PFMT (t0) | After PFMT (t3) | Change in points | ||
|---|---|---|---|---|---|
| KHQ1 | General health perception | 54.48±18.02 | 38.46±12.62 | 16.02 | <0.0001 |
| KHQ2 | Incontinence impact | 51.27±18.48 | 38.45±14.38 | 12.82 | 0.001 |
| KQH3 | Role limitations | 48.71±23.99 | 33.33±0 | 15.38 | 0.001 |
| KHQ4 | Physical limitations | 49.14±30.09 | 42.30±24.13 | 6.84 | 0.006 |
| KHQ5 | Social limitations | 36.74±30.06 | 30.19±19.23 | 6.55 | 0.010 |
| KHQ6 | Personal relationships | 16.92±32.10 | 11.11±21.40 | 5.81 | 0.045 |
| KHQ7 | Emotions | 39.59±29.81 | 18.80±16.93 | 20.79 | 0.0003 |
| KHQ8 | Sleep/energy | 15.38±16.83 | 13.24±13.34 | 2.14 | 0.44 |
| KHQ9 | Severity measures | 44.43±22.07 | 29.26±16.87 | 15.17 | 0.001 |
| KHQ10 | Symptom severity scale | 5.38±3.70 | 4.46±2.90 | 0.92 | 0.074 |
Values are given as mean±SD, P value: Paired t-test/Wilcoxon signed-rank test, <0.05 is significant. KHQ: King’s Health Questionnaire, SD: Standard deviation, PFMT: Pelvic floor muscle training
Comparison of various domains of King’s Health Questionnaire before and 3 months after no treatment (n=18)
| Domains | No treatment (t0) | No treatment (t3) | Change in points | ||
|---|---|---|---|---|---|
| KHQ1 | General health perception | 41.66±17.14 | 36.11±12.78 | 5.55 | 0.10 |
| KHQ2 | Incontinence impact | 49.99±23.57 | 46.29±23.25 | 3.7 | 0.05 |
| KQH3 | Role limitations | 33.32±29.70 | 27.77±24.25 | 5.55 | 0.36 |
| KHQ4 | Physical limitations | 37.02±28.89 | 36.10±24.42 | 0.92 | 0.655 |
| KHQ5 | Social limitations | 28.70±30.85 | 29.62±29.27 | −0.92 | 0.65 |
| KHQ6 | Personal relationships | 11.11±19.80 | 11.11±16.16 | 0 | 0.6 |
| KHQ7 | Emotions | 27.15±25.90 | 22.22±18.66 | 4.93 | 0.197 |
| KHQ8 | Sleep/energy | 13.88±16.41 | 12.95±13.46 | 0.93 | 0.63 |
| KHQ9 | Severity measures | 28.69±21.62 | 25.92±17.82 | 2.77 | 0.285 |
| KHQ10 | Symptom severity scale | 4.72±4.32 | 3.77±2.42 | 0.95 | 0.052 |
Values are given as mean±SD, P value: Paired t-test/Wilcoxon signed-rank test, <0.05 is significant. KHQ: King’s Health Questionnaire, SD: Standard deviation
Comparison between the improvement in quality of life in the study arms (tension-free vaginal tape-obturator, pelvic floor muscle training, and no treatment group)
| Tool number | Domains | TVT-O group ( | PFMT group ( | Nil intervention group ( | |
|---|---|---|---|---|---|
| KHQ1 | General health perceptions | 40 | 16.02 | 5.55 | <0.001 |
| KHQ2 | Incontinence impact | 58.33 | 12.82 | 3.7 | <0.001 |
| KQH3 | Role limitations | 53.33 | 15.38 | 5.55 | <0.001 |
| KHQ4 | Physical limitations | 48.33 | 6.84 | 0.92 | <0.001 |
| KHQ5 | Social limitations | 49.16 | 6.55 | −0.92 | <0.001 |
| KHQ6 | Personal relationships | 29.42 | 5.81 | 0 | <0.001 |
| KHQ7 | Emotions | 51.66 | 20.79 | 4.93 | <0.001 |
| KHQ8 | Sleep/energy | 51.67 | 2.14 | 0.93 | <0.001 |
| KHQ9 | Severity measures | 43.75 | 15.17 | 2.77 | <0.001 |
| KHQ10 | Symptom severity score | 5.6 | 0.92 | 0.95 | <0.001 |
Values are given as mean±SD, P value: Multivariate ANOVA, <0.05 is significant. KHQ: King’s Health Questionnaire, SD: Standard deviation, PFMT: Pelvic floor muscle training, TVT-O: Tension-free vaginal tape-obturator, ANOVA: Analysis of variance